PHARMACY PROGRAMME STRATEGIC PLAN
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
1
PHARMACEUTICAL SERVICES DIVISION
Ministry of Health Malaysia
PHARMACY
PROGRAMME
STRATEGIC PLAN
1
FOREWORD
T
he Ministry of Health is pleased to present the Pharmacy Programme
Strategic Plan which sets into motion a four-year programme
mapping the way forward. The plan outlines their strategic
vision supported by the core thrusts, strategies and
initiatives that are synergistically moulded in order
to achieve the mission and vision of the
Pharmacy Programme.
The plan addresses the need to provide sustainable,
high-quality pharmacy services in a complex and
evolving environment. The plan clearly defines the direction of
the Programme and sets priorities for action that can be implemented
at national, regional and local levels.
The Pharmacy services play an integral role in the healthcare service delivery system. It
offers a wide range of services spanning from primary and secondary care and enforcement
of law that includes, but not limited to pharmaceutical products and cosmetics. The Pharmacy
plan also supports the pharmaceutical industry by providing the regulatory backbone to ensure
further growth and expansion of this vital and dynamic sector. Greater collaboration and
cooperation between the various healthcare stakeholders will boost the country’s economy and
improve quality of life for all.
I wish to sincerely acknowledge the dedication and effort of all who have participated in the
development of this plan under the leadership of the Senior Director of the Pharmaceutical
Services for the formulation of the 2017-2020 Pharmacy Programme Strategic Plan. I am
certain that the success of the plan will have a positive impact on our robust healthcare system.
Together we will strive towards improving the country’s healthcare needs.
DATUK DR. NOOR HISHAM BIN ABDULLAH
DIRECTOR GENERAL OF HEALTH
MINISTRY OF HEALTH MALAYSIA
2 PHARMACY PROGRAMME STRATEGIC PLAN
2017-2020
FOREWORD
T
he Eleventh Malaysia Plan (2016-2020) has mapped the last leg of our
path to reach Vision 2020. Accordingly, the Ministry of Health (MOH)
has charted the way forward for the nation’s health services
through the MOH Strategic Plan 2016-2020 as well as the
Health Transformation Plan to support the national
agenda in achieving better health for the nation.
It is imperative for us to develop our strategic
plan to guide the organisation towards achieving a
common goal. With the overarching National Medicines
Policy, key strategies are drawn up by analysing the current
situation, our strengths and weaknesses and projecting the future needs.
As part of the team that will carry out this mission, the Pharmaceutical Services
Programme MOH is focused on intensifying customer engagement in order to reach a wider
population and increasing public awareness on their roles and responsibilities towards health.
From the organisation aspect, we will improve operational excellence where resources will be used
optimally to ensure responsive, efficient service and effective policy implementation.
The Pharmaceutical Services Programme is committed to stay ahead and keep up with changing
times. Implementation of innovative pharmacy service delivery and the strengthening of ICT system
readiness will create value for the customers and enhance the future delivery of healthcare to the
nation. Innovation in pharmacy services will be supported mainly by initiatives in ICT-based systems
such as PhIS, MyPharma-C and Quest 3+ by the National Pharmacy Regulatory Agency. Translation
of research findings into the development of policy and practice are crucial for efficient organisation
management and ensuring subsequent actions taken by the Programme are beneficial to the
nation. We will also commit to boosting capability building by focusing on skills and knowledge
enhancement in new areas as well as developing expertise in various pharmacy fields.
I believe, with the collaborated effort from all, we will implement this plan successfully and
overcome the challenges and issues in the future. Let us work together as a team to achieve better
health for the nation.
DR. SALMAH BINTI BAHRI, RPh 783
SENIOR DIRECTOR OF PHARMACEUTICAL SERVICES PROGRAMME
MINISTRY OF HEALTH MALAYSIA
3
FOREWORD
T
he Pharmacy Programme Strategic Plan (2017-2020) is an important
document that determines the direction of the Pharmacy
Programme in carrying out its role in accordance with
the aspirations of the government. This strategic plan
is an initial step to ensure the development of
Pharmacy Programme which is in line with
the government and the ministry’s mission
and vision in strengthening the health system
transformation.
The Strategic Plan focuses on four main aspects, namely
strengthening the governance of Pharmacy Programme, strengthening
service delivery through innovation and technology, strengthening the
skills, expertise and human resource capacity, and enhancing cooperation with
stakeholders and empowering communities on quality use of medicines. The strategies
and initiatives outlined in this plan will also have an impact on the development of pharmacy
services in the future. In carrying out this mission, every member of Pharmacy Programme
should instil and uphold the shared values and leadership practices identified in this document.
Finally, I would like to extend my earnest appreciation to all parties involved in the realization of
this strategic plan. I hope that every member of the Pharmacy Programme is fully committed
to the success of this plan.
DR. RAMLI BIN ZAINAL, RPh 1045
DIRECTOR OF PHARMACY POLICY AND STRATEGIC PLANNING DIVISION
MINISTRY OF HEALTH MALAYSIA
4 PHARMACY PROGRAMME STRATEGIC PLAN
2017-2020
INTRODUCTION
The Pharmacy Programme of the Ministry of Health (MOH), established in 1951, is the lead agency
that ensures the public gets access to safe, efficacious and quality pharmaceutical products, protecting
their interest via enforcement of relevant legislations, and ensuring rational use of medicines by both
healthcare providers and patients.
The Programme consists of five main divisions headed by a Senior Director of Pharmaceutical Services.
These five main Divisions are Pharmacy Policy and Strategic Planning Division, Pharmacy Practice and
Development Division, Pharmacy Enforcement Division, National Pharmaceutical Regulatory Agency
(NPRA) and Pharmacy Board Malaysia. Each division plays important roles in different aspects and
approaches with the same objective that is giving the best professional pharmacy service to the public.
Pharmacy Programme Strategic Plan 2017-2020 outlines the strategic directions of the Pharmacy
Programme for a period of 4 years with four main focuses:
5
STRATEGIC PLAN
ALIGNMENT
This strategic plan was developed with a view to the future direction of Pharmacy Programme in aligning with the
needs and the current situation of the government’s plans. The fundamentals of this strategic plan are based on:
MNMP MOH
Equitable access & rational • Strengthen delivery of
use of safe, effective & healthcare (primary care)
affordable medicines of good • Health system governance
quality to improve health • Empowering community
outcomes of the people • Intensify collaboration
11th MALAYSIAN HSTP
PLAN • Revitalising capability building
Achieving universal access to • Re-engineering organisations
quality healthcare • Enhancing service delivery
• Intensify collaboration
• Enculturing corporate culture
A B C D
Strategic Thrust 2 of Health Services Ministry of Health Malaysian National
11th Malaysia Plan Transformation Plan (MOH) Strategic Plan Medicines Policy (MNMP),
Improving well being (HSTP), Ministry of 2016-2020 2013-2020
for all Health, Malaysia • Strengthening the Malaysian National Medicines
• Priority focus area • Developing talented healthcare service Policy (MNMP) objective is to
is to achieve health workforce delivery especially in promote equitable access and
universal access • Strengthening the primary healthcare rational use of safe, effective
to quality healthcare health policies and • Strengthening health and affordable essential
public organisational systems governance medicines of good quality to
capacity and organisational improve health outcomes of the
• Enhancing health capabilities nations. Five core components
services delivery • Empowering in MNMP are:
• Intensify health individuals, families, • Governance in Medicines
collaboration the community • Access to Medicines
• Inculcate corporate toward better health • Quality, Safety and Efficacy
culture values awareness of Medicines
• Intensify the • Quality Use of Medicines
collaboration between • Partnership and
the public, private and Collaboration for the
NGO Healthcare Industry
6 PHARMACY PROGRAMME STRATEGIC PLAN
2017-2020
DIVISIONS’
OBJECTIVES
NATIONAL
PHARMACY PHARMACY
PRACTICE & REGULATORY AGENCY
DEVELOPMENT DIVISION we will
we will • Ensure that products approved
• Ensure continuous access to the quality, for the local market are safe and of
safe and cost-effective medicines. quality and also ensure that natural
• Strengthen the quality and rational use of products and cosmetics are
medicines towards the better health. safe and of quality.
• Enhance pharmaceutical care PHARMACY
services in line with the good ENFORCEMENT
standards and practices. DIVISION
we will
• Ensure all sales, supply, PHARMACY
possession and advertising of BOARD OF MALAYSIA
PHARMACY
POLICY & STRATEGIC
substances, products and we will
cosmetics are in • Ensure the registration of pharmacists
PLANNING DIVISION
compliance with the and bodies corporate complies with
we will legal provisions. Registration of Pharmacists Act 1951
• Develop policies for the and its regulations.
pharmaceutical sector in line with the • Set the standard for conduct, ethics,
needs of national healthcare. proficiency, education and training
• Ensure excellent and efficient and Continuous Professional
resources management. Development (CPD).
RELATED SALE OF DRUGS
ACT 1952
REGISTRATION OF
PHARMACISTS ACT 1951
ACTS AND • Control of Drugs
and Cosmetics
• Registration of Pharmacists
Regulations 2004
REGULATIONS Regulations 1984
POISONS ACT 1952 MEDICINES POISONS (SODIUM
• Poisons Regulations 1952 (ADVERTISEMENT HYDROXIDE)
• Poisons (Fees) Regulations 1983 AND SALE) ACT 1956 REGULATIONS 1962
• Poisons (Psychotropic • Medicine
Substances) Regulations 1989 Advertisements SALE OF DRUGS
Board Regulations (CERTIFICATE OF ANALYSIS)
1976 REGULATIONS 1997PHARMACY PROGRAMME STRATEGIC PLAN
2017-2020
To enhance the nation’s health
OUR VISION through excellence in the practice of pharmacy
We aim to uphold legislations and improve policies to We aim to build capabilities and professionalism through
ensure quality of pharmaceutical products and services talent development and workforce empowerment
OUR MISSION
We aim to ensure effective and responsive organisational We aim to intensify collaboration towards best practices
system towards sustainable quality services and standards
4 STRATEGIC THRUSTS
CUSTOMER ENGAGEMENT OPERATIONAL EXCELLENCE CAPABILITY BUILDINGS
INNOVATION DRIVEN The element of an organisational Process of developing and strengthening
The quality of the customer
Translating ideas and innovations into leadership that applies a variety of
experience that emphasises the the skills, abilities and resources that
positive aspects of the interaction service that creates value for our principles, systems towards a
organisations need to adapt and thrive
with our organisation. customers. sustainable improvement of key
performance matrix. in a changing environment.
Improve accessibility of
Implement innovative pharmacy pharmaceutical products
service delivery Improve efficiency and optimise Enhance human resource
Enhance multi sector
ICT-based service innovation expenditure competency and performance
engagement towards better
health awareness Enhance research and Strengthen monitoring activities of Optimise human resource
knowledge sharing unregistered products capacity to ensure continuous
Enhance value proposition of
Enhance business process and Strengthen governance and service delivery
pharmacy services
product safety regulatory control
Enhance organisational efficiency
SHARED VALUES PROFESSIONALISME INTEGRITY CUSTOMER CARE TEAMWORK EFFICIENT
INSPIRE A CHALLENGE ENABLE OTHERS ENCOURAGE THE
LEADERSHIP PRACTICES MODEL THE WAY SHARED VISION THE PROCESS TO ACT HEART
78
STRATEGIC THRUSTS AND PLAN OF ACTIONS
2017-2020
PHARMACY PROGRAMME STRATEGIC PLAN
CUSTOMER ENGAGEMENT
THE QUALITY OF THE CUSTOMER EXPERIENCE THAT EMPHASISES THE POSITIVE ASPECTS OF THE INTERACTION WITH OUR ORGANISATION
Strategy Initiative Strategy/Initiative Details Performance Indicator Target by Year 2020
STRATEGY 1: Number of Engagement
Enhance Multi Sector
Engagement Towards
Better Health Awareness
Initiative 1: To conduct dialogue sessions Percentage of PBT covered
Engagement with local council followed by joined operations
100%
in reducing unapproved medical to withdraw illegal medicine
advertisement advertisements OPS 3B
Initiative 2: Engagement with local RTM’s radio Percentage of local RTM’s radio
Engagement with local media in station through dialogue session station covered
100%
reducing unapproved medical
advertisement
Initiative 3: This initiative is focusing Number of NGO/society/
Engaging NGOs/professional on engagement with NGOs/ government agency engaged
society/ government agency to professional society/government (cumulative)
5
reach specific group towards agency as a collaborative effort to
quality use of medicines (QUM) & educate and increase awareness on
customer protection Quality Use of Medicines
STRATEGY 2: This initiative aims to enhance the 1. Customer Perception on
Enhance Value Proposition promotion of pharmacy services profession and service Increasing trend
of Pharmacy Services 2. Service Uptake Rate
Initiative 1: This initiative aims to promote the Improve community perception
Increased community
Enhance promotion of pharmacy availability of pharmacy services towards pharmacy services and
awareness towards
services in MOH facility in order to improve professional image
pharmacy services
service uptakeINNOVATION DRIVEN
TRANSLATING IDEAS AND INNOVATIONS INTO SERVICE THAT CREATES VALUE FOR OUR CUSTOMERS
Strategy Initiative Strategy/Initiative Details Performance Indicator Target by Year 2020
STRATEGY 1: Number of innovative pharmacy
Implementation of services delivery implemented by
2
Innovative Pharmacy year 2020
Service Delivery
Initiative 1: This initiative aims to increase Number of new centres
Expansion of Integrated Drug patient access to their medicine established (increasing trend)
Delivery System through value added service 45 centres
and ensuring continuity of their
medication supply
Initiative 2: This initiative focuses on patients Percentage of medical wards
Medicines Optimisation and their experiences with the implementing Patient Own 75% of medical ward in
goals to help patients to improve Medications (POMs) Programmes State and Major Specialist
treatment outcomes and avoid Hospital
taking unnecessary medicines, 25% of medical ward in
reduce wastage as well as improve Minor Specialist Hospital
medication safety
Percentage of facilities All State hospital
implementing Program Bekas Ubat All Major Specialist
Hospital
26 Minor Specialist
Hospital
30% of Health Clinics
STRATEGY 2: No. of ICT-based system 19 independent systems
ICT-based Service developed developed
Innovation No. of ICT-based system integrated 3 integrated systems
910
2017-2020
PHARMACY PROGRAMME STRATEGIC PLAN
Strategy Initiative Strategy/Initiative Details Performance Indicator Target by Year 2020
Initiative 1: This initiative aims to improve Number of manual work process
14 identified manual
Business Process Reengineering efficiency of service delivery through innovated
processes transformed to
(BPR) of manual work process to transformation of manual work
online based service
ICT-based process into online based services
Initiative 2: This initiative focuses to integrate Integration of the system by year
Integration of ICT-based systems 5 existing independent systems 2020
to improve systems efficiency and
Integration of :
optimise data sharing.
1. Mypharma-C + SPIKE
2. MyPharma-C + QUEST
The systems are:
project
- MyPharma-C
3. QUEST + PhIS
- SPIKE
- QUEST
- MERs
- PhIS/CPS
Initiative 3: Pharmaceutical Track & Trace 1st phase Pharmaceutical Track & 1st phase Pharmaceutical
Implementation of System is an initiative to improve Trace System implemented by the Track & Trace System
Pharmaceutical Track & Trace patient safety and optimisation of year 2019 implemented by the year
System logistic management 2019
Initiatives 4: PhIS is a web-based drug Percentage of ARU 100% availability
Optimisation of PhIS in MOH management system to be fully (Availability, Reliability and 95% reliability
facilities utilised in all MOH facilities by the Utilisation) (Utilisation: incremental
year 2020 trend 2018-2020)
STRATEGY 3: Number of articles/technical 60 articles/technical
Enhance Research and reports published reports
Knowledge Sharing (incremental trend
2017-2020)Strategy Initiative Strategy/Initiative Details Performance Indicator Target by Year 2020
Initiative 1: This initiative aims to encourage Percentage of pharmacy facilities
Intensify research based on pharmacists/pharmacy assistants within MOH conducting research
priority area identified to conduct researches based on 95% pharmacy facilities
Pharmacy Programme Research conducting research
Priority Framework
(Standard, Year 2015:50%)
Initiative 2: This initiative aims to intensify Number of research presented
Intensify knowledge sharing knowledge sharing in research. 370 researches presented
in research through multiple Researches are encouraged to be (incremental trend
platforms presented in various platforms (local 2017-2020)
and international level)
STRATEGY 4: Number of private laboratories
5 private laboratories
Enhance Business Process recognised
recognised
and Product Safety
Initiative 1: This initiative aims to recognise Number of private laboratories
Recognition of private private laboratories with the recognised
laboratories (conducting test for capacities to provide testing for;
5 private laboratories
traditional products) - Heavy Metal
recognised
- Microbial Contamination
- Uniformity of Weight
- Disintegration
Initiative 2: This initiative will enable NPRA to Registration testing for traditional All registration testing
Privatisation of pre-registration redeploy resources for new services products fully conducted by conducted by private
testing for traditional product recognised private laboratories laboratories by year 2020
by 2020
1112
2017-2020
PHARMACY PROGRAMME STRATEGIC PLAN
OPERATIONAL EXCELLENCE
THE ELEMENT OF ORGANISATIONAL LEADERSHIP THAT APPLIES A VARIETY OF PRINCIPLES, SYSTEMS AND TOOLS TOWARD
THE SUSTAINABLE IMPROVEMENTOF KEY PERFORMANCE METRICS
Strategy Initiative Strategy/Initiative Details Performance Indicator Target by Year 2020
STRATEGY 1: Implementation of Price Setting Both initiated and
Improve Accessibility of mechanism and patient access implemented
Pharmaceutical Products scheme
Initiative 1: Price Setting for medicines will be Price Setting mechanism is Price Setting Mechanisms
Implementation of Price Setting done through the development of implemented is implemented by 2019
mechanism a mechanism for price setting in Consumer Medicine Price
cooperation with relevant authorities is published by 2019
Initiative 2: This programme is designed to Number of patient access scheme
Improving access to affordable improve patient access to high cost (PAS) implemented
2 schemes implemented
medicine through patient access medicines
scheme (PAS)
STRATEGY 2: Percentage of dossier received
10% of dossier received
Improve Efficiency & with local PE study (10% by 2020)
with local PE study
Optimise Expenditure
Initiative 1: This initiative aims to encourage Percentage of dossier received
Utilisation of local pharmacoeconomic studies utilising with local PE study (10% by 2020)
10% of dossier received
Pharmacoeconomic [PE] data local data through establishment of
with local PE study
in the selection of medicines for PE Centre
formulary listing
STRATEGY 3: No. of licences premise and media
Strengthen monitoring platform monitored
activities of unregistered
productsStrategy Initiative Strategy/Initiative Details Performance Indicator Target by Year 2020
Initiative 1: DiPS: Didik, Pantau and Serbu is Percentage of targeted premises
Reduction of targeted
Expand the “Didik, Pantau and a systematic approach to reduce selling unregistered products
premises selling
Serbu (DiPS)” approach to the sales of unregistered products
unregistered products by
hotspot areas through awareness and surveillance
80% in year 2020
amongst retailers
Initiative 2: A social media and instant The number of social media
Monitoring sales of unregistered messaging (IM) platform is a platforms and IM platforms
products and cosmetics in Web-based technology that enables monitored
the social media and instant the development, deployment and 25 platforms monitored
messaging platforms management of social media and
instant messaging solutions and
services
STRATEGY 4: Establishment of NPRA as a
Strengthen Governance & certified Conformity Assessment
Regulatory Control Body (CAB) by 2018
Initiative 1: This initiative aims to enhance Certification as a CAB
Certified as a CAB by
Establishment of NPRA as a regulatory control and governance of
Medical Device Authority
certified Conformity Assessment NPRA in medical device
by 2018
Body (CAB)
Initiative 2: This initiative aims to enhance Vaccine testing method developed
Three (3) vaccine testing
Enhance Regulatory Control regulatory control in vaccine through
method developed by
of Vaccine in the Aspects of collaboration with identified partner
2018
Laboratory Testing in developing vaccine testing method
STRATEGY 5: Establishment NPRA and LFM as
Enhance Organisational Statutory Body Finalisation of Bill by 2020
Efficiency
1314
2017-2020
PHARMACY PROGRAMME STRATEGIC PLAN
Strategy Initiative Strategy/Initiative Details Performance Indicator Target by Year 2020
Initiative 1: This initiative focuses on Finalisation of bill
Establishment of National enhancing NPRA efficiency through
Finalisation of bill as a
Pharmaceutical Regulatory establishment as statutory body
statutory body by 2020
Agency (NPRA) as a statutory
body
Initiative 2: This initiative focuses on Finalisation of bill
Establishment of Malaysia enhancing LFM efficiency through Finalisation of bill as a
Pharmacy Board (LFM) as a establishment as statutory body statutory body by 2020
statutory body
CAPABILITY BUILDING
PROCESS OF DEVELOPING AND STRENGTHENING THE SKILLS, ABILITIES AND RESOURCES THAT
ORGANISATIONS NEED TO ADAPT AND THRIVE IN A CHANGING ENVIRONMENT
Strategy Initiative Strategy/Initiative Details Performance Indicator Target by Year 2020
STRATEGY 1: Capability building Framework
Enhance Human Resource developed Framework completed
Competency and by 2019
Performance
Initiative 1: This initiative aims to develop a Capability building framework
Develop capability building framework that offer an overview of developed Framework developed by
framework (technical & the various career options along with year 2020
management) education and trainingStrategy Initiative Strategy/Initiative Details Performance Indicator Target by Year 2020
Initiative 2: C&P is a program to credential 1. No. of identified areas of practice
Expansion of credentialing and qualified individuals in identified established
privileging (C&P) activity areas of practice C&P established for all
Area of Practice: 2. No. of qualified pharmacists identified area of practice
- Enforcement (Cyber Forensic) being credentialed
- Clinical 30 qualified pharmacists
- Pharmacy Practice credentialed
- R&D
- Regulatory
Initiative 3: Subject Matter Expert is a form Establishment of Subject Matter
Establishment of Subject Matter of recognition to an individual Expert (SME) Programme in SME program established
Expert (SME) Programme in pharmacist who is an expert in a pharmacy by 2020
pharmacy services particular area/field
Initiative 4: To conduct a special training with Number of officers undergo training
Enhance officers’ capability accredited forensic agency and certified
100% officers certified in
to carry out analysis of digital
advanced level
evidence (Cyber Forensic
Laboratory)
STRATEGY 2: Percentage of MOH facilities
Optimise Human Resource achieved more than 80% posts
80%
Capacity to Ensure filled
Continuous Service Delivery
Initiative 1: Identifying the staffing needs using Staffing guidelines developed
Staffing guidelines
Develop Staffing Guidelines based Workload Indicator for Staffing Needs
developed by 2020
on facility workload (WISN)
Initiative 2: To ensure number of facilities Percentage of facility achieving the
Redeployment of pharmacy staff (hospital & health clinics) achieving agreed ratio or WISN ratio of 1
More than 75% of facility
to achieve a balanced WISN ratio balance WISN ratio of 1 or agreed
achieved the agreed ratio
ratio
or WISN ratio of 1
(WISN ratio of 1 indicates balanced
workload and manpower)
1516 PHARMACY PROGRAMME STRATEGIC PLAN
2017-2020
ACKNOWLEDGEMENT
Pharmacy Policy and Strategic Planning Division would like to express gratitude and appreciation to
the following participants for their support and contribution in the preparation of this document. The
success and final outcome of this document required a lot of guidance and assistance from many
people and we were extremely fortunate to have this all along until the completion of the document.
• Pharmacy Practice and Development Division
• Pharmacy Enforcement Division
• National Pharmaceutical Regulatory Agency (NPRA)
• Pharmacy Board Malaysia
• Deputy Director (Pharmacy) State Health Department
• State Pharmacy Representatives18 PHARMACY PROGRAMME STRATEGIC PLAN
2017-2020
PHARMACEUTICAL SERVICES DIVISION
Ministry of Health Malaysia
Lot 36, Jalan Universiti
46350 Petaling Jaya
Selangor
T 03-7841 3200
F 03-7968 2222
www.pharmacy.gov.myYou can also read
